PS
EDIT icon

Principal Securities’s Editas Medicine EDIT Stock Holding History

Principal Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-575
Closed -$2K – 1935
2025
Q3 		$2K Sell
575
-103
-15% -$287 ﹤0.01% 3235
2025
Q2 		$1.49K Buy
678
+433
+177% +$708 ﹤0.01% 3232
2025
Q1 		$311 Hold
245
– – ﹤0.01% 3418
2024
Q4 		$311 Hold
245
– – ﹤0.01% 3413
2024
Q3 		$835 Buy
245
+50
+26% +$218 ﹤0.01% 3175
2024
Q2 		$911 Sell
195
-8
-4% -$45 ﹤0.01% 3090
2024
Q1 		$1.51K Sell
203
-66
-25% -$548 ﹤0.01% 2946
2023
Q4 		$2.73K Buy
+269
New +$2.36K ﹤0.01% 2727

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Principal Securities's EDIT Position: Q4 2025 in Review

Principal Securities sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 575 shares — an estimated $2K sold.

Principal Securities first reported a position in EDIT in Q4 2023 and held it in 8 quarters. The position peaked at $2.73K in Q4 2023. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Principal Securities reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 575 Editas Medicine shares in Q4 2025, an estimated $2K.
  • Principal Securities first reported a position in Editas Medicine in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Editas Medicine position peaked at $2.73K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.